Home health services provider Amedisys Inc. said Monday that it has agreed to buy Boston-based hospice company Beacon Hospice for about $125 million.

Beacon has 23 free-standing locations and one inpatient unit, serving Massachusetts, Maine, New Hampshire, Rhode Island and Connecticut. Its Maine offices are in Augusta, Bangor, Lewiston, Portland and York.

Amedisys said Beacon’s 2021 revenue was about $80 million.

William F. Borne, the CEO of Amedisys, said Beacon serves as a “great complement to our home health business,” with many of its hospice locations matching the market presence of its existing home health services business. Beacon’s 1,300 average daily patients will increase the number of hospice patients under Amedisys’s care by nearly 40 percent.

Shares of Amedisys slid 50 cents to $34.06 amid a broader market decline.

Only subscribers are eligible to post comments. Please subscribe or to participate in the conversation. Here’s why.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.